Press Room

There are 1 item(s) tagged with the keyword "Reducing with MetfOrmin Vascular Adverse Lesions".

1. JDRF-Funded Study Seeks to Reduce Cardiovascular Risk in Adults with Type 1 Diabetes

New York, NY, December  13, 2011-JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes (T1D) in the REMOVAL study, to test whether metformin-a drug commonly used to treat type 2 diabetes-could help prevent or reduce the risk of cardiovascular complications in people w...

Lets turn type one into type none